Models

Submission ID Name Format Sort Ascending Submitter Submitted Modified Certification
DDMODEL00000003 Hamren_2008_diabetes_tesaglitazar PharmML 0.8.x Paolo Magni 2014/09/25 2016/10/10 uncertified model
DDMODEL00000122 Samtani_2010_Hb1Ac_prediction PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/10 uncertified model
DDMODEL00000113 Russu_2009_dose_escalation_loglog PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000008 Rocchetti_2013_oncology_TGI_combo PharmML 0.8.x Paolo Magni 2014/09/26 2016/10/10 uncertified model
DDMODEL00000118 Friedrich_2014_PK PharmML 0.8.x Paolo Magni 2015/12/12 2016/10/13 uncertified model
DDMODEL00000103 Trefz_2015_metabolism_Kuvan_TurnoverKPD PharmML Nadia Terranova 2015/12/11 2016/07/18 uncertified model
DDMODEL00000090 Claret_2009_oncology_capecitabine_TGI PharmML Nadia Terranova 2015/12/10 2016/07/13 uncertified model
DDMODEL00000213 Li_2006_PK_Meropenem_AdultPatients PharmML Lisa Ehmann 2016/08/26 2016/08/30 uncertified model
DDMODEL00000186 Friberg_2002_Oncology_Paclitaxel_Myelosuppression PharmML Zinnia Parra-Guillen 2016/05/17 2016/08/24 uncertified model
DDMODEL00000229 A model for monoclonal antibody-based targeted therapy of Gemtuzumab Ozogamicin (GO) for acute myeloid leukemia (AML) PharmML Moran Optimata 2016/10/26 2016/11/01 uncertified model
Showing 21 to 30 of 151 models
First Previous 3 4 5 6 7 Next Last
 
Help